[en] The polymerization of peptidoglycan is the result of two types of enzymatic activities: transglycosylation, the formation of linear glycan chains, and transpeptidation, the formation of peptide cross-bridges between the glycan strands. Staphylococcus aureus has four penicillin binding proteins (PBP1 to PBP4) with transpeptidation activity, one of which, PBP2, is a bifunctional enzyme that is also capable of catalyzing transglycosylation reactions. Additionally, two monofunctional transglycosylases have been reported in S. aureus: MGT, which has been shown to have in vitro transglycosylase activity, and a second putative transglycosylase, SgtA, identified only by sequence analysis. We have now shown that purified SgtA has in vitro transglycosylase activity and that both MGT and SgtA are not essential in S. aureus. However, in the absence of PBP2 transglycosylase activity, MGT but not SgtA becomes essential for cell viability. This indicates that S. aureus cells require one transglycosylase for survival, either PBP2 or MGT, both of which can act as the sole synthetic transglycosylase for cell wall synthesis. We have also shown that both MGT and SgtA interact with PBP2 and other enzymes involved in cell wall synthesis in a bacterial two-hybrid assay, suggesting that these enzymes may work in collaboration as part of a larger, as-yet-uncharacterized cell wall-synthetic complex.
Arbeloa, A., et al. 2004. Role of class A penicillin-binding proteins in PBP5-mediated β-lactam resistance in Enterococcus faecalis. J. Bacteriol. 186: 1221-1228.
Arnaud, M., A. Chastanet, and M. Débarouillé. 2004. New vector for efficient allelic replacement in naturally nontransformable, low-GC-content, grampositive bacteria. Appl. Environ. Microbiol. 70:6887-6891.
Atilano, M. L., et al. 2010. Teichoic acids are temporal and spatial regulators of peptidoglycan cross-linking in Staphylococcus aureus. Proc. Natl. Acad. Sci. U. S. A. 107:18991-18996.
Barrett, D., et al. 2005. Kinetic characterization of the glycosyltransferase module of Staphylococcus aureus PBP2. J. Bacteriol. 187:2215-2217.
Canavessi, A. M. O., J. Harms, N. de Leon Gatti, and G. A. Splitter. 2004. The role of integrase/recombinase xerD and monofunctional biosynthesis peptidoglycan transglycosylase genes in pathogenicity of Brucella abortus infection in vitro and in vivo. Microb. Pathog. 37:241-251.
Chambers, H. F. 2001. The changing epidemiology of Staphylococcus aureus. Emerg. Infect. Dis. 7:178-182.
Coutinho, P. M., E. Deleury, G. J. Davies, and B. Henrissat. 2003. An evolving hierarchical family classification for transglycosylases. J. Mol. Biol. 328:307-317.
Di Berardino, M., A. Dijkstra, D. Stuber, W. Keck, and M. Gubler. 1996. The monofunctional glycosyltransferase of Escherichia coli is a member of a new class of peptidoglycan synthesising enzymes. FEBS Lett. 392:184-188.
Gill, S. R., et al. 2005. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J. Bacteriol. 187:2426-2438.
Goffin, C., and J. M. Ghuysen. 1998. Multimodular penicillin-binding proteins: an enigmatic family of orthologs and paralogs. Microbiol. Mol. Biol. Rev. 62:1079-1093.
Hartman, B. J., and A. Tomasz. 1984. Low-affinity penicillin-binding protein associated with β-lactam resistance in Staphylococcus aureus. J. Bacteriol. 158:513-516.
Heaslet, H., B. Shaw, A. Mistry, and A. Miller. 2009. Characterization of the active site of S. aureus monofunctional transglycosylase (Mtg) by site-directed mutation and structural analysis of the protein complexed with moenomycin. J. Struct. Biol. 167:129-135.
Hoskins, J., et al. 1999. Gene disruption studies of penicillin-binding proteins 1a, 1b, and 2a in Streptococcus pneumoniae. J. Bacteriol. 181:6552-6555.
Huber, G., and G. Nesemann. 1968. Moenomycin, an inhibitor of cell wall synthesis. Biochem. Biophys. Res. Commun. 30:7-13.
Huber, G. 1979. Moenomycin and related phosphorus-containing antibiotics, p. 135-153. In F. E. Hahn (ed.), Antibioticas, vol. I. Mechanism of action of antibacterial agents. Springer Verlag, Berlin, Germany.
Karimova, G., J. Pidoux, A. Ullmann, and D. Ladant. 1998. A bacterial two-hybrid system based on a reconstituted signal transduction pathway. Proc. Natl. Acad. Sci. U. S. A. 95:5752-5756.
Komatsuzawa, H., J. Suzuki, M. Sugai, Y. Miyake, and H. Suginaka. 1994. Effect of combination of oxacillin and non-β-lactam antibiotics on methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 33:1155-1163.
Kunst, F., et al. 1997. The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature 390:249-256.
Kuroda, M., et al. 2001. Whole genome sequencing of methicillin-resistant Staphylococcus aureus. Lancet 357:1225-1240.
Lowy, F. D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339: 520-532.
McPherson, D. C., and D. L. Popham. 2003. Peptidoglycan synthesis in the absence of class A penicillin-binding proteins in Bacillus subtilis. J. Bacteriol. 185:1423-1431.
Miller, J. H. 1992. A short course in bacterial genetics. A laboratory manual and handbook for Escherichia coli and related bacteria. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
Oshida, T., and A. Tomasz. 1992. Isolation and characterization of a TN551-autolysis mutant of Staphylococcus aureus. J. Bacteriol. 174:4952-4959.
Pinho, M. G., S. R. Filipe, H. De Lencastre, and A. Tomasz. 2001. Complementation of the essential peptidoglycan transpeptidase function of penicillin-binding protein 2 (PBP2) by the drug resistance protein PBP2A in Staphylococcus aureus. J. Bacteriol. 183:6525-6531.
Pinho, M. G., H. De Lencastre, and A. Tomasz. 2001. An acquired and a native PBP cooperate in building the cell wall of drug-resistant staphylococci. Proc. Natl. Acad. Sci. U. S. A. 98:10886-10891.
Reynolds, P. E., and D. F. Brown. 1985. Penicillin-binding proteins of β-lactam resistant strains of Staphylococcus aureus. Effect of growth conditions. FEBS Lett. 192:28-32.
Reynolds, P. E. 1989. Structure, biochemistry, and mechanism of action of glycopeptide antibiotics. Eur. J. Clin. Microbiol. Infect. Dis. 8:943-950.
Rice, L. B., et al. 2009. Role of class A penicillin-binding proteins in the expression of β-lactam resistance in Enterococcus faecium. J. Bacteriol. 191: 3649-3656.
Schiffer, G., and J. V. Holtje. 1999. Cloning and characterization of PBP 1C a third member of the multimodular class A penicillin-binding proteins of Escherichia coli. J. Biol. Chem. 274:32031-32039.
Spratt, B. G., J. Zhou, M. Taylor, and M. J. Merrick. 1996. Monofunctional biosynthetic peptidoglycan transglycosylases. Mol. Microbiol. 19:639-640.
Terrak, M., et al. 1999. The catalytic, glycosyl transferase and acyl transferase modules of the cell wall peptidoglycan-polymerising penicillin binding protein 1b of Escherichia coli. Mol. Microbiol. 34:350-364.
Terrak, M., and M. Nguyen-Disteche. 2006. Kinetic characterization of the monofunctional transglycosylase from Staphylococcus aureus. J. Bacteriol. 188:2528-2532.
Utaida, S., et al. 2003. Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wallstress stimulon. Microbiology 149:2719-2732.
van Heijenoort, Y., M. Gomez, M. Derrien, J. Ayala, and J. van Heijenoort. 1992. Membrane intermediates in the peptidoglycan metabolism of Escherichia coli: possible roles of PBP1b and PBP3. J. Bacteriol. 174:3549-3557.
Veiga, H., and M. G. Pinho. 2009. Inactivation of the SauI restrictionmodification system is not sufficient to generate Staphylococcus aureus strains capable of efficiently accepting foreign DNA. Appl. Environ. Microbiol. 75:3034-3038.
Wang, Q. M., et al. 2001. Identification and characterization of a monofunctional transglycosylase from Staphylococcus aureus. J. Bacteriol. 183:4779-4785.
Yansura, D. G., and D. J. Henner. 1984. Use of the Escherichia coli lac repressor and operator to control gene expression in Bacillus subtilis. Proc. Natl. Acad. Sci. U. S. A. 81:439-443.
Zetola, N., J. S. Francis, E. L. Nuermberger, and W. R. Bishai. 2005. Community-acquired meticillin resistant Staphylococcus aureus: an emerging threat. Lancet Infect. Dis. 5:275-286.